| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $273.0M | +9.0% |
| R&D Expense | $6.1M | -6.2% |
| SG&A Expense | $51.4M | +18.4% |
| Operating Income | $7.4M | +882.9% |
| Pre-tax Income | -$2.8M | +95.5% |
| Income Tax | $5.9M | +175.3% |
| Net Income | -$8.7M | +86.3% |
| EPS (Basic) | -$0.15 | +74.6% |
| EPS (Diluted) | -$0.15 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $447.5M | +14.4% |
| Accounts Receivable | $20.0M | -25.9% |
| Inventory | $9.6M | -10.5% |
| Current Assets | $496.7M | +11.0% |
| Total Assets | $2.33B | +36.0% |
| Current Liabilities | $205.5M | +45.2% |
| Long-term Debt | $483.8M | -5.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $621.6M | +41.5% |
| Investing Cash Flow | -$550.4M | -111.2% |
| Financing Cash Flow | -$16.2M | -110.3% |
| +74.6% |
| Total Liabilities |
| $1.97B |
| +45.8% |
| Stockholders' Equity | $355.7M | -0.9% |